Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ralf Lorenz"'
Autor:
Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-11 (2020)
Abstract Background When chemotherapy is indicated in patients with early breast cancer, regimens that contain anthracyclines and taxanes are established standard treatments. Gemcitabine has shown promising effects on the response and prognosis in pa
Externí odkaz:
https://doaj.org/article/41e6c37d4d19434583b0e8de81ad13a2
MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients
Autor:
Hanna Huebner, Lothar Häberle, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Visnja Fink, Fabienne Schochter, Inga Bekes, Sven Mahner, Julia Jückstock, Naiba Nabieva, Andreas Schneeweiss, Hans Tesch, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Mahdi Rezai, Matthias W. Beckmann, Peter A. Fasching, Wolfgang Janni, Brigitte Rack
Publikováno v:
Cancers, Vol 14, Iss 7, p 1721 (2022)
Soluble MUC1 has been discussed as a biomarker for predicting prognosis, treatment efficacy, and monitoring disease activity in breast cancer (BC) patients. Most studies in adjuvant settings have used preoperative assessment. This study, part of the
Externí odkaz:
https://doaj.org/article/d83c2b6f90764c77a58c56a3072e7728
Autor:
Marianna Alunni-Fabbroni, Leonie Majunke, Elisabeth K. Trapp, Marie Tzschaschel, Sven Mahner, Peter A. Fasching, Tanja Fehm, Andreas Schneeweiss, Thomas Beck, Ralf Lorenz, Thomas W. P. Friedl, Wolfgang Janni, Brigitte Rack, on behalf of the SUCCESS Study Group
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background microRNAs (miRNAs) are considered promising cancer biomarkers, showing high reliability, sensitivity and stability. Our study aimed to identify associations between whole blood miRNA profiles, presence of circulating tumor cells (
Externí odkaz:
https://doaj.org/article/35021f3d4cbf4fba95d7c6d5747e931e
Autor:
Wolfgang Janni, Leonie Majunke, Tanja Fehm, Sven Mahner, Ralf Lorenz, Thomas L. Beck, Elisabeth Trapp, Marie Tzschaschel, Marianna Alunni-Fabbroni, Andreas Schneeweiss, Thomas W. P. Friedl, Brigitte Rack, Peter A. Fasching
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Cancer
BMC Cancer
Background microRNAs (miRNAs) are considered promising cancer biomarkers, showing high reliability, sensitivity and stability. Our study aimed to identify associations between whole blood miRNA profiles, presence of circulating tumor cells (CTCs) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb378d6a8f6075fc78f5ed12e1c488c4
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/9696
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/9696
Autor:
Ralf Lorenz, Christoph Scholz, Wolfgang Janni, Hans Tesch, Brigitte Rack, Peter A. Fasching, Lothar Haeberle, Tanja Fehm, Werner Lichtenegger, Thomas W. P. Friedl, Matthias W. Beckmann, Andreas Schneeweiss, M Tzschaschel, Klaus Pantel, Amelie de Gregorio, Fabienne Schochter, Volkmar Müller
Publikováno v:
Journal of Clinical Oncology. 36:515-515
515Background: Recent data suggest that circulating tumor cells (CTCs) are of prognostic relevance in early as well as metastatic breast cancer. However, there is a lack of data on the prognostic i...
Autor:
Christian Schindlbeck, Twp Friedl, Werner Lichtenegger, J Gade, Marianna Alunni-Fabbroni, Klaus Pantel, E Trapp, Wolfgang Janni, Hans Tesch, U Soeling, Mahdi Rezai, Mlj Tzschaschel, Arkadius Polasik, Ralf Lorenz, Andreas Schneeweiss, PA Fasching, M. W. Beckmann, Volkmar Mueller, F Tanja, Brigitte Rack, S Mahner, Ulrich Andergassen
Publikováno v:
Cancer Research. 77:P1-01
Background: The presence of circulating tumor cells (CTCs) before chemotherapy is known to be associated with reduced disease free survival (DFS) and overall survival (OS) in early breast cancer (EBC). In addition, recent findings suggest that CTCs p
Autor:
Bernadette Anna Sophia Jaeger, Carsten Hagenbeck, Georg Heinrich, N Kasprowicz, Matthias W. Beckmann, C Melcher, Andreas Schneeweiss, Brigitte Rack, Thomas Zwingers, Tanja Fehm, Helmut Forstbauer, Hans Ulrich Ulmer, Uta Ortmann, Werner Lichtenegger, Ralf Lorenz, Christoph Scholz, Wolfgang Janni
Publikováno v:
Journal of Clinical Oncology. 30:1602-1602
1602 Background: Independent from known prognostic factors, e.g., tumor size and nodal status, obesity is a risk factor for poor disease free, distant disease free, and overall survival in breast cancer. The aim of this analysis was to examine the co
Autor:
Wolfgang Janni, Hans Tesch, Klaus Pantel, Ralf Lorenz, Christian Schindlbeck, Andreas Schneeweiss, M. W. Beckmann, Brigitte Rack, Bernadette Jäger, Werner Lichtenegger
Publikováno v:
European Journal of Cancer. 48:S130